NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] Error in table step

From: Mark Sale <msale_at_nuventra.com>
Date: Sun, 27 Sep 2015 13:29:26 +0000

Dear colleagues:


I have a very large model (lots of ODEs, lots of data, long duration), runn=
ing parallel across several machines, using SAEM. Runs reasonably well. B=
ut, fails the $TABLE with this error:

0PROGRAM TERMINATED BY FNLETA
0PRED EXIT CODE = 1
0INDIVIDUAL NO. 3 ID= 5.10000000000000E+01 (WITHIN-INDIVIDUAL) =
DATA REC NO. 1
 THETA=
  0.00E+00 1.19E+00 2.59E-01 5.68E+00 2.64E-01 5.69E+00 2.35E+0=
0 4.17E-01 4.20E-04 6.50E-01
  3.98E-01 1.86E-01 -3.50E-01 -2.09E-01 -1.87E+00 2.09E-01 1.85E-0=
1 -1.90E-01 1.30E+00 4.82E-01
  0.00E+00 9.54E-01 1.34E+03 1.19E+00 3.44E-01 1.78E+03
 OCCURS DURING SEARCH FOR ETA AT INITIAL VALUE, ETA=0
 F OR DERIVATIVE RETURNED BY PRED IS INFINITE (INF) OR NOT A NUMBER (NAN).
0PROGRAM TERMINATED BY FNLETA
 MESSAGE ISSUED FROM TABLE STEP


All the THETA values of 0.00 are fixed to that value. All the other values =
are very reasonable.


So, I don't get any tables, can't to a VPC etc. I've tried running FOCE, n=
o better. Tried error checking that F is always positive, tried EXIT if F =
is very small, I have the NOABORT option set (but I don't think that is rel=
evant in the $TABLE step).


I assume it is crashing calculating the conditional ETAs (don't know why it=
 does OK in estimation). PRDERR only has the small number of error from th=
e estimation


Anyone seen this error, any suggestions on how to get rid of it (other than=
 removeing subject 51)?


Mark



Mark Sale M.D.
Vice President, Modeling and Simulation
Nuventra, Inc. ™
2525 Meridian Parkway, Suite 280
Research Triangle Park, NC 27713
Office (919)-973-0383
msale_at_nuventra.com<msale_at_kinetigen.com>
www.nuventra.com<http://www.nuventra.com>



Empower your Pipeline

CONFIDENTIALITY NOTICE The information in this transmittal (including attac=
hments, if any) may be privileged and confidential and is intended only for=
 the recipient(s) listed above. Any review, use, disclosure, distribution o=
r copying of this transmittal, in any form, is prohibited except by or on b=
ehalf of the intended recipient(s). If you have received this transmittal i=
n error, please notify me immediately by reply email and destroy all copies=
 of the transmittal.



________________________________
From: owner-nmusers_at_globomaxnm.com <owner-nmusers_at_globomaxnm.com> on behalf=
 of nonmem <nonmem_at_optonline.net>
Sent: Wednesday, September 23, 2015 6:47 PM
To: Spilker, Mary; nmusers_at_globomaxnm.com
Subject: RE: [NMusers] PK-PD Modeling position available (Pfizer Location: =
La Jolla, CA)

Dear Mary, l may be over qualified for the position. My current position i=
s equal to associate director level at Regeneron and my experience exceeds =
2 years significantly. Thank you, Pavel



Sent via the Samsung Galaxy S® 5 ACTIVE™, an AT&T 4G LTE smartphone


-------- Original message --------
From: "Spilker, Mary" <Mary.Spilker_at_pfizer.com>
Date: 09/23/2015 12:49 PM (GMT-05:00)
To: nmusers_at_globomaxnm.com
Subject: [NMusers] PK-PD Modeling position available (Pfizer Location: La J=
olla, CA)

All over the world, Pfizer colleagues are working together to positively im=
pact health for everyone, everywhere. Each position at Pfizer touches and c=
ontributes to the success of our business and our world. That’s why, as o=
ne of the global leaders in the biopharmaceutical industry, Pfizer is commi=
tted to seeking out inspired new talent who share our core values and missi=
on of making the world a healthier place.

Job Summary

A PK-PD Principal Scientist position is available in the Translational Mode=
ling and Simulation group within Pharmacokinetics, Dynamics and Metabolism =
(PDM) New Biologic Entities (NBE). The successful applicant will apply stat=
e-of-the-art modeling and simulation methods to preclinical studies that en=
able key drug discovery decisions from early discovery stages to the first-=
in-human study. As a member of multidisciplinary project teams, the candida=
te will develop and implement quantitative mechanism-based PK-PD models whi=
ch impact the quality of decisions regarding target prioritization, therape=
utic modality selection, biomarker characterization, chemical, biotherapeut=
ic optimization and early clinical trial design. The individual will have a=
n opportunity to support a wide range of projects, largely, but not exclusi=
vely, in the Oncology therapeutic area, covering small molecules and biothe=
rapeutic modalities.

Education & Training

This individual should hold a Ph.D. or equivalent degree in systems biology=
, pharmacometrics, pharmaceutical sciences, (bio)engineering, mathematics o=
r similar disciplines where modeling and simulation is emphasized, and 2+ y=
ears of industrial experience in practical applications of modeling and sim=
ulation, including direct discovery project support.

Equal Employment Opportunity

Pfizer is committed to equal opportunity in the terms and conditions of emp=
loyment for all employees and job applicants without regard to race, color,=
 religion, sex, sexual orientation, age, gender identity or gender expressi=
on, national origin, disability or veteran status. Pfizer also complies wit=
h all applicable national, state and local laws governing nondiscrimination=
 in employment as well as work authorization and employment eligibility ver=
ification requirements of the Immigration and Nationality Act and IRCA. Pfi=
zer is an E-Verify employer.

How to Apply

To learn more about this exciting opportunity, please visit http://www.pfiz=
ercareers.com. Search for job ID 1019326 and submit your application online=
.




Received on Sun Sep 27 2015 - 09:29:26 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request_at_iconplc.com. Once subscribed, you may contribute to the discussion by emailing: nmusers_at_globomaxnm.com.